Profilo
Jeffrey Alan Morhet is the founder of ThirdBiotech, Inc., VentureBeacon, Inc. Prior to founding these companies, he worked as Chairman, President & CEO at InNexus Biotechnology, Inc. He also worked as Product Director at Integrated Physician Network and as Vice President & General Manager at Zila, Inc. Morhet is a graduate of Stephen F.
Austin State University.
Precedenti posizioni note di Jeffrey Alan Morhet
Società | Posizione | Fine |
---|---|---|
Zila, Inc.
Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use | Corporate Officer/Principal | 01/01/2004 |
Integrated Physician Network | Corporate Officer/Principal | 01/01/2002 |
ThirdBiotech, Inc. | Fondatore | - |
VentureBeacon, Inc. | Fondatore | - |
INNEXUS BIOTECHNOLOGY, INC. | Amministratore Delegato | - |
Formazione di Jeffrey Alan Morhet
Stephen F. Austin State University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
INNEXUS BIOTECHNOLOGY, INC. | Health Technology |
Aziende private | 4 |
---|---|
Zila, Inc.
Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use | Health Technology |
ThirdBiotech, Inc. | |
VentureBeacon, Inc. | |
Integrated Physician Network |
- Borsa valori
- Insiders
- Jeffrey Alan Morhet